We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Ondine Biomedical Inc. | LSE:OBI | London | Ordinary Share | CA68234M2058 | COM SHS NPV (CDI) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.00 | 0.00% | 9.00 | 8.50 | 9.50 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 9.00 | 8.85 | 9.00 | 118,335 | 08:00:21 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Biological Pds,ex Diagnstics | 1.2M | -14.41M | -0.0357 | -2.52 | 36.36M |
| Date | Time | Source | Headline |
|---|---|---|---|
| 30/12/2024 | 09:51 | ALNC |  Ondine Biomedical reports "exciting milestone" in US phase 3 trial |
| 30/12/2024 | 07:00 | UK RNS | Ondine Biomedical Inc. Ondine recruits first patient for US Phase 3 trial |
| 17/12/2024 | 07:00 | UK RNS | Ondine Biomedical Inc. Ondine commencing US Phase 3 clinical trial |
| 25/11/2024 | 17:00 | UK RNS | Ondine Biomedical Inc. Notification of Major Holdings |
| 22/11/2024 | 10:31 | UK RNS | Ondine Biomedical Inc. Notification of Major Holdings |
| 22/11/2024 | 08:30 | UK RNS | Ondine Biomedical Inc. Director Holdings |
| 18/11/2024 | 17:00 | UK RNS | Ondine Biomedical Inc. NOTIFICATION OF MAJOR HOLDINGS |
| 15/11/2024 | 15:30 | UK RNS | Ondine Biomedical Inc. Final Result of Fundraise & TVR |
| 14/11/2024 | 07:00 | UK RNS | Ondine Biomedical Inc. Updated Result of Fundraise |
| 11/11/2024 | 07:00 | UK RNS | Ondine Biomedical Inc. Update on Private Placement and Placing |
1 Year Ondine Biomedical Chart |
Intraday Ondine Biomedical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
